New insights into an enigmatic tumour suppressor
- 1 January 2003
- journal article
- editorial
- Published by Springer Nature in Nature Cell Biology
- Vol. 5 (1) , 7-8
- https://doi.org/10.1038/ncb0103-7
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Regulation of microtubule stability by the von Hippel-Lindau tumour suppressor protein pVHLNature Cell Biology, 2002
- Molecular basis of the VHL hereditary cancer syndromeNature Reviews Cancer, 2002
- Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau proteinCancer Cell, 2002
- Critical role for the EB1 and APC interaction in the regulation of microtubule polymerizationPublished by Elsevier ,2001
- Contrasting effects on HIF-1alpha regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau diseaseHuman Molecular Genetics, 2001
- von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIFHuman Molecular Genetics, 2001
- A CINtillating New Job for the APC Tumor SuppressorScience, 2001
- VHL Induces Renal Cell Differentiation and Growth Arrest through Integration of Cell-Cell and Cell-Extracellular Matrix SignalingMolecular and Cellular Biology, 2001
- Adenomatous Polyposis Coli (APC) Protein Moves along Microtubules and Concentrates at Their Growing Ends in Epithelial CellsThe Journal of cell biology, 2000
- Tumour suppression by the human von Hippel-Lindau gene productNature Medicine, 1995